It is amazing, we were always told that a "one for all strip" would be impossible. Probably due to the slow FDA process they found a way to bypass this. It seems for this brilliant team there are no boundaries to get a grip into the Glucose Monitoring market. Now 6 more products DECN can have a bite into. That is how much additional percentage to the already targeted 71% of the total market?
GoDECN!
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links